Login | Register
Profile | Log out
logo

  • Home
  • News
  • Opinion
  • Other
    • Market Updates
    • Explainers
    • Satire
  • About
  • Contact Us
    • Contact
    • Get Covered
    • Posting Guidelines
  • Subscribe
Submit An Article

Latest Articles

  • Nanoveu Secures $2 Million to Fast-Track Commercial Launch of ECS-DoT Chip and AIoT Platform
    Nanoveu Secures $2 Million to Fast-Track Commercial Launch of ECS-DoT Chip and AIoT Platform
    • News

  • Archer Unlocks Cryogenic Sensor Breakthrough for Quantum Computing
    Archer Unlocks Cryogenic Sensor Breakthrough for Quantum Computing
    • News

  • EGL Secures $1.9M PFAS Plant Contract as Demand for Clean-Up Technologies Surges
    EGL Secures $1.9M PFAS Plant Contract as Demand for Clean-Up Technologies Surges
    • News

  • RocketDNA Secures Major Aerial Tech Contract with Vault Minerals at WA Gold Site
    RocketDNA Secures Major Aerial Tech Contract with Vault Minerals at WA Gold Site
    • News

  • BirdDog Boosts Buy-Back Offer by 40% Ahead of ASX Delisting Vote
    BirdDog Boosts Buy-Back Offer by 40% Ahead of ASX Delisting Vote
    • News

  • AML3D Launches High-Tech U.S. Facility to Power Submarine Supply Chain
    AML3D Launches High-Tech U.S. Facility to Power Submarine Supply Chain
    • News

  • Vection Enters $520K Agritech Deal to Build AI-Powered Farming Robot
    Vection Enters $520K Agritech Deal to Build AI-Powered Farming Robot
    • News

  • Unith Achieves Strong Growth in Platform Usage and Strategic Partnerships
    Unith Achieves Strong Growth in Platform Usage and Strategic Partnerships
    • News

  • FBR and Samsung Heavy Industries Execute Engineering Service Agreement for Shipbuilding Automation Project
    FBR and Samsung Heavy Industries Execute Engineering Service Agreement for Shipbuilding Automation Project
    • News

  • Bioxyne Lifts FY2025 Revenue Forecast as Psychedelics and Pharma Push Gains Pace
    Bioxyne Lifts FY2025 Revenue Forecast as Psychedelics and Pharma Push Gains Pace
    • News

Nutritional Growth Solutions reaching new heights with market expansion into China

  • In News
  • August 9, 2021
  • Samantha Freidin
Nutritional Growth Solutions reaching new heights with market expansion into China

Nutritional Growth Solutions (ASX: NGS) is reaching new heights on their growth chart with expansion into global markets, confirming the launch of their proprietary Healthy Height® shake range in Chemist Warehouse in China.

Addressing an overlooked subset of the nutritional supplement market, NGS creates clinically proven supplements to support healthy growth and development in children aged 3-12 years. Their proprietary formulations are the result of decades of medical research into paediatric nutrition to create a product with a large market opportunity, highly differentiated from its competitors. So far, the Company has commercialised both a nutritional shake and a snack bar in various markets.

Chemist Warehouse is Australia’s largest pharmacy retailer with stores also operating in New Zealand, China and Ireland. The non-exclusive supply agreement with NGS will see their Healthy Height® shake range stocked both in-store and online on the Chemist Warehouse China T-Mall Global online store. T-Mall is the largest and most reputable eCommerce platform in China giving brands access to millions of shoppers. The platform is fast becoming an essential strategy for many retailers wanting to enter the market.

The supply agreement comes after the appointment of a Commercial Director for China earlier this year.

Nutritional Growth Solutions CEO and Managing Director, Liron Fendell said: “We are excited to embark on this new partnership with Chemist Warehouse China and launching the Healthy Height® shake range across its high performing physical and online stores in China, especially online through T-Mall global where it has broken numerous sales records since its launch in 2015.”

“Whilst the agreement does not contain minimum order sizes and the Company cannot provide a revenue projection at this stage, this agreement represents a significant achievement for the Company as an important distribution channel into China.

“This agreement places us ahead of schedule for our medium-term expansion plans, now with a physical presence through a big-name stockist, a secured trademark to protect our brand, a production partner in New Zealand to manufacture, license, package and assist commercialisation in the Asia Pacific, and a newly appointed Commercial Director who is already making headways in the region.”

The growing focus on health has contributed to the rush to food supplements in China with more and more international brands such as Amway and Blackmores infiltrating the Chinese market. According to market experts, the sale of vitamins and dietary supplements has multiplied by 5 since the beginning of the COVID-19 pandemic. Whilst NGS holds a unique position within a niche, there is still plenty of opportunity to tap into the USD $22.3 billion market.

NGS reported record quarterly revenue of over USD $1 million, up 90% on the prior corresponding period and a strong cash position of USD $2.7 million as at June 30, 2021

  • About
  • Latest Posts
Samantha Freidin
Samantha Freidin is a business journalist at Emerald Financial whilst also completing a Masters of Marketing and Digital Communications at Monash University.
Latest posts by Samantha Freidin (see all)
  • Parkinson’s UK backs Pharmaxis with $5 million to slow the onset of incurable disease with ‘ground breaking’ trial - September 1, 2022
  • How this company is developing medtech to support Indigenous community health - August 22, 2022
  • A round of ap-paws for PharmAust, changing the ruff prognosis for dogs with lymphoma - August 17, 2022
  •  
  •  
  •  
  •  
  • asx ngs
  • Chemist Warehouse
  • ngs
  • nutritional growth solutions
  • paediatric nutrition
  • t-mall
  • News

Leave a Comment

You must be logged in to post a comment.

  • About
  • Latest Posts
Samantha Freidin
Samantha Freidin is a business journalist at Emerald Financial whilst also completing a Masters of Marketing and Digital Communications at Monash University.
Latest posts by Samantha Freidin (see all)
  • Parkinson’s UK backs Pharmaxis with $5 million to slow the onset of incurable disease with ‘ground breaking’ trial - September 1, 2022
  • How this company is developing medtech to support Indigenous community health - August 22, 2022
  • A round of ap-paws for PharmAust, changing the ruff prognosis for dogs with lymphoma - August 17, 2022

Login or register for free to access unlimited reading

Register Now!
  • About
  • Latest Posts
Samantha Freidin
Samantha Freidin is a business journalist at Emerald Financial whilst also completing a Masters of Marketing and Digital Communications at Monash University.
Latest posts by Samantha Freidin (see all)
  • Parkinson’s UK backs Pharmaxis with $5 million to slow the onset of incurable disease with ‘ground breaking’ trial - September 1, 2022
  • How this company is developing medtech to support Indigenous community health - August 22, 2022
  • A round of ap-paws for PharmAust, changing the ruff prognosis for dogs with lymphoma - August 17, 2022
  • News

  • Opinion

  • Satire

  • About

  • Contact Us

  • Subscribe

The content published on this website is solely for general information purposes and is not to be construed as financial advice. Should you seek financial advice you should consult with an appropriately qualified person. Opinions expressed on this site are subject to change without notice and The Sentiment who produced this content is under no obligation to keep the information current. The Sentiment, affiliated companies & associates may have a conflict of interest with companies discussed on the website due to commercial arrangements, for example they may be shareholders in the company, be engaged by them to assist in investor communications or receive commission/brokerage for funds raised.

Copyright © 2020 The Sentiment. All rights reserved.
Subscribe

Enter your email address below to subscribe to The Sentiment’s weekly newsletter, highlighting the top news, research, opinion and satire articles shaping ASX investor sentiment.

The Sentiment respects your privacy and will not spam you. View our privacy policy here.